Results 81 to 90 of about 89,048 (269)

Supplemental material for Etoposide and etoposide phosphate hypersensitivity in children: Incidence, risk factors, and prevention strategies

open access: yes, 2019
Supplemental Material for Etoposide and etoposide phosphate hypersensitivity in children: Incidence, risk factors, and prevention strategies by Winifred M Stockton, Theresa Nguyen, Lishi Zhang and Thomas C Dowling in Journal of Oncology Pharmacy ...
Lishi Zhang (3710122)   +3 more
core   +1 more source

Mesenchymal Chondrosarcoma Presenting as Atypical Brown–Sequard Syndrome

open access: yes
Annals of the Child Neurology Society, EarlyView.
Naman D. Shah   +4 more
wiley   +1 more source

Successfully performed video capsule endoscopy in an 8‐month‐old infant weighing 7.5 kg

open access: yesJPGN Reports, EarlyView.
Abstract Video capsule endoscopy (VCE) is a well‐established diagnostic tool for examining the small bowel. Limited data exist on its use in infants. To our knowledge, we present the first detailed case of a successful PillCam®SB3‐VCE performed in an 8‐month‐old infant weighing 7.5 kg with suspected small bowel bleeding following allogeneic ...
Paul‐Christoph Zeisler   +3 more
wiley   +1 more source

Gas chromatography–mass spectrometry analysis and comprehensive evaluation of antibacterial, antioxidant and anti‐inflammatory properties of Thymus capitatus extracts from Libya

open access: yesJSFA reports, EarlyView.
Abstract Background The emergence of multidrug‐resistant bacteria necessitates the development of alternative therapeutic approaches. Thymus capitatus, a Mediterranean medicinal plant, has been traditionally used to treat various ailments, but its bioactive potential from Libyan origins remains underexplored.
Ahmed Saeed Kabbashi   +9 more
wiley   +1 more source

A novel mutation panel for predicting etoposide resistance in small-cell lung cancer

open access: yesDrug Design, Development and Therapy, 2019
Zhengang Qiu,1,2,* Anqi Lin,1,* Kun Li,1,* Weiyin Lin,1,* Qiongyao Wang,1 Ting Wei,1 Weiliang Zhu,1 Peng Luo,1 Jian Zhang11Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, People’s Republic of China ...
Qiu Z   +8 more
doaj  

Etoposide treatment resulted in poor-quality embryos.

open access: yes, 2015
(A) Schematic diagram of 7-day-old embryos. The blastocyst rates and cell numbers were lower after 25 and 100 μg/mL etoposide treatment. We found that the etoposide-treated embryos contained multiple micronuclei. (B) Cell numbers in etoposide-treated (0,
In-Won Lee (824606)   +6 more
core   +1 more source

Aliphatic Poly(Carbonate)s with Acid Responsive Release Mechanisms for Micellar Anti‐Tumor Drug Delivery

open access: yesMacromolecular Rapid Communications, EarlyView.
Micellar systems based on biodegradable aliphatic polycarbonates and acid‐responsive triggers enhance drug solubility, stability, and tumor‐selective release. This review covers micelles with acid‐cleavable drug linkages and those that disassemble via acid‐sensitive functionalities.
Adrian V. Hauck, Lutz Nuhn
wiley   +1 more source

Bioequivalence assessment of etoposide phosphate and etoposide using pharmacodynamic and traditional pharmacokinetic parameters

open access: yes, 1996
The bioequivalence of etoposide phosphate, a prodrug of etoposide, to etoposide was assessed in a randomized crossover study in 29 patients with histologically established solid tumors that had failed conventional treatment.
Winograd B   +8 more
core  

Cisplatin-based chemotherapy of testicular cancer - Two decades after a major breakthrough [PDF]

open access: yes, 2000
Two decades ago the introduction of cisplatin-based combination chemotherapy has dramatically improved the prognosis of patients with metastatic testicular cancer, At present 3 cycles of cisplatin, etoposide and bleomycin are considered as standard ...
Gerl, Arthur
core   +1 more source

Myasthenia Gravis and Thymoma

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy